D. Gozal, NOCTURNAL VENTILATORY SUPPORT IN PATIENTS WITH CYSTIC-FIBROSIS - COMPARISON WITH SUPPLEMENTAL OXYGEN, The European respiratory journal, 10(9), 1997, pp. 1999-2003
Progressive deterioration of lung function in cystic fibrosis (CF) pat
ients may lead to significant hypoxaemia and hypercapnia, especially d
uring sleep. The effects of bilevel noninvasive positive pressure nasa
l mask ventilation (NIPPV) on respiration and sleep were compared to t
hose of low-flow oxygen therapy in six CF patients (mean+/-SD age 22.3
+/-4.7 yrs, with severe lung disease (forced expiratory volume in one
second (FEV1) 29.4+/-3.4% predicted). Compared to the control night, N
IPPV and oxygen therapy significantly improved overall night-time oxyg
en saturation during both rapid eye movement (REM) and non-rapid eye m
ovement (NREM) sleep stages. However, significant increases in transcu
taneous CO2 tension occurred during oxygen therapy, while NIPPV marked
ly improved alveolar ventilation during all sleep states, Sleep archit
ecture and arousals remained unchanged during NIPPV and oxygen therapy
treatment nights. We conclude that noninvasive positive pressure vent
ilation improves sleep-related hypoxaemia and hypercapnia in severe cy
stic fibrosis patients without affecting sleep, The long-term complian
ce and benefits of noninvasive positive pressure ventilation remain un
clear.